Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.

Khoshkam, Zahra; Aftabi, Younes; Stenvinkel, Peter; Paige Lawrence, B; Rezaei, Mehran Habibi; Ichihara, Gaku; Fereidouni, Sasan

Khoshkam, Zahra; Aftabi, Younes; Stenvinkel, Peter; Paige Lawrence, B; Rezaei, Mehran Habibi; Ichihara, Gaku; Fereidouni, Sasan.

Afiliación

Khoshkam Z; Department of Molecular and Cell Biology, Faculty of Basic Sciences, University of Tehran, Tehran, Iran.
Aftabi Y; Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Stenvinkel P; Department of Interdisciplinary Life Sciences, University of Veterinary Medicine Vienna, Vienna, Austria.
Paige Lawrence B; Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.
Rezaei MH; Departments of Environmental Medicine and Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY, USA.
Ichihara G; Department of Molecular and Cell Biology, Faculty of Basic Sciences, University of Tehran, Tehran, Iran.
Fereidouni S; Department of Occupational and Environmental Health, Faculty of Pharmaceutical Sciences Tokyo University of Science, Noda, Japan.

J Adv Res ; 31: 49-60, 2021 07.

Article en En | MEDLINE | ID: mdl-33520309

Asunto(s)

Anticuerpos Neutralizantes/inmunología; Anticuerpos Antivirales/inmunología; COVID-19/inmunología; Reinfección/inmunología; SARS-CoV-2/inmunología; Vacunación/métodos; Enzima Convertidora de Angiotensina 2/metabolismo; Animales; Progresión de la Enfermedad; Humanos; Inmunidad Humoral; Inflamación/inmunología; Inflamación/metabolismo; Macaca/inmunología; Macaca/virología; Pandemias; Reinfección/virología; Linfocitos T/inmunología

Palabras clave

ACE2, Angiotensin-converting enzyme 2; ADE, Antibody-dependent enhancement; ARDS, Acute respiratory distress syndrome; Ang II, Angiotensin II; BAL, Bronchoalveolar lavage; COVID-19; COVID-19, Coronavirus disease 2019; Coronavirus; ERS, Early recovery stage; FcR, Fc receptor; ISGs, Interferon-stimulated genes; Immunity; LRS, Late recovery stage; N, Nucleocapsid; NAb, Neutralizing antibody; NK, Natural killer; PBMCs, Peripheral blood mononuclear cells; PSO, Post symptom onset; RBD, Receptor-binding domain; RT-PCR, Real-time reverse transcriptasepolymerase chain reaction; Recovery; Reinfection; SARS-CoV-2; SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2; sACE2, Soluble ACE2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_transmissiveis / 2_enfermedades_transmissibles / 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases Asunto principal: Vacunación / Anticuerpos Neutralizantes / Reinfección / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: J Adv Res Año: 2021 Tipo del documento: Article País de afiliación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google